Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey D Bloss

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Gynecologic Oncology|August 21, 2003
Gemcitabine in cervical cancerDavid G Mutch, Jeffrey D Bloss
Gynecologic Oncology|August 21, 2003
Treatment of ovarian cancer: new strategiesPhilip J DiSaia, Jeffrey D Bloss
American Journal of Obstetrics and Gynecology|June 21, 2008
Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studiesSteven C Plaxe, Sandra E Brooks, Chunquiao Tian, et al.
Gynecologic Oncology|October 27, 2009
Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group StudyDavid H Moore, Chunqiao Tian, Bradley J Monk, et al.
Gynecologic Oncology|April 16, 2003
Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group StudyJeffrey D Bloss, Mark F Brady, Shu Yuan Liao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group studyJeffrey D Bloss, John A Blessing, Brent C Behrens, et al.
Gynecologic Oncology|February 27, 2004
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyHenry M Keys, James A Roberts, Virginia L Brunetto, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology|August 21, 2003
Gemcitabine in cervical cancerDavid G Mutch, Jeffrey D Bloss
Gynecologic Oncology|August 21, 2003
Treatment of ovarian cancer: new strategiesPhilip J DiSaia, Jeffrey D Bloss
American Journal of Obstetrics and Gynecology|June 21, 2008
Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studiesSteven C Plaxe, Sandra E Brooks, Chunquiao Tian, et al.
Gynecologic Oncology|October 27, 2009
Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group StudyDavid H Moore, Chunqiao Tian, Bradley J Monk, et al.
Gynecologic Oncology|April 16, 2003
Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group StudyJeffrey D Bloss, Mark F Brady, Shu Yuan Liao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group studyJeffrey D Bloss, John A Blessing, Brent C Behrens, et al.
Gynecologic Oncology|February 27, 2004
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyHenry M Keys, James A Roberts, Virginia L Brunetto, et al.
Pageof 1